Author:
Nakamura Yoshinobu,Kishimoto Yuichirou,Harada Shingo,Onohara Takeshi,Otsuki Yuki,Horie Hiromu,Nishimura Motonobu
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Kishimoto Y, Nakamura Y, Harada S, Onohara T, Kishimoto S, Kurashiki T, et al. Can tolvaptan protect renal function in the early postoperative period of cardiac surgery? Results of a single-center randomized controlled study. Circ J. 2018;82:999–1007.
2. Butterworth JF, Prielipp RC. Endocrine, metabolic, and electrolyte responses. In: Gravlee GP, Davis RF, Kurusz M, Utley JR, editors. Cardiopulmonary bypass principles and practice. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 342–366.
3. Kalman JM, Munawar M, Howes LG, Louis WJ, Buxton BF, Gutteridge G, et al. Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg. 1995;60:1709–15.
4. Ambrosy A, Goldsmith SR, Gheorghiade M. Tolvaptan for the treatment of heart failure: a review of the literature. Expert Opin Pharmacother. 2011;12:961–76.
5. Villareal RP, Hariharan R, Liu BC, Kar B, Lee VV, Elayda M, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43:742–8.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献